The Korean Journal of Physiology & Pharmacology

Indexed in SCIE, Scopus, PubMed & PMC

pISSN 1226-4512 eISSN 2093-3827

Crossmark

home

Policy

Crossmark

CrossMark is a multi-publisher initiative to provide a standard way for readers to locate the current version of a piece of content.

By applying the CrossMark logo, The Korean Journal of Physiology & Pharmacology (Korean J Physiol Pharmacol), a CrossRef sponsoring member publisher for major Korean medical journals) is committing to maintaining the content it publishes and to alerting readers to changes if and when they occur.

Clicking on the CrossMark logo will tell you the current status of a document and may also give you additional publication record information about the document.

Current Issue

March 2025
Vol.29 No.2

Current Issue
All Issues

Journal Impact Factor (2023) 1.6

Most Read

Ferroptosis and its role in gastric and colorectal cancers

Jinxiu Hou¹, Bo Wang¹, Jing Li², and Wenbo Liu^3,*

2024; 28(3): 183-196
https://doi.org/10.4196/kjpp.2024.28.3.183
Dexmedetomidine alleviates blood-brain barrier disruption in rats after cerebral ischemia-reperfusion by suppressing JNK and p38 MAPK signaling

Canmin Zhu¹, Dili Wang¹, Chang Chang¹, Aofei Liu^2,3, Ji Zhou^2,3, Ting Yang¹, Yuanfeng Jiang^2,3, Xia Li^2,3, and Weijian Jiang^2,*

2024; 28(3): 239-252
https://doi.org/10.4196/kjpp.2024.28.3.239

Close ✕

The Korean Physiological Society The Korean Society of Pharmacology

- Article
  - • Current Issue
  - • Archive
  - • Most Read
  - • KJPP on
- About KJPP
  - • Aims and Scope
  - • Contact Us
- Editors
  - • Editorial board
  - • Editors Emeriti
- For Contributors
  - • Instruction for
    Authors
  - • EndNote Style
- Submission
  - • Submit a
    Manuscript
  - • Submission
    Fees
- Policy
  - • Review Policy
  - • Open Access
  - • ORCID

ⓒ 2019. The Korean Journal of Physiology & Pharmacology. Powered by INFOrang Co., Ltd